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http://dx.doi.org/10.1016/j.ccell.2015.03.002SUMMARYMany types of human cancers having hyperactivatedWnt signaling display no causative alterations in known
effectors of this pathway. Here, we report a function of TGIF in Wnt signaling. TGIF associates with and
diverts Axin1 and Axin2 from the b-catenin destruction complex, therefore allowing b-catenin accrual.
Intriguingly, activation of Wnt signaling induces the expression of TGIF, which unveils a feed-forward loop
that ensures effective integration of Wnt signaling. In triple-negative breast cancers (TNBC), elevated levels
of TGIF correlate with high Wnt signaling and poor survival of patients. Moreover, genetic experiments re-
vealed that Tgif1 ablation impeded mammary tumor development inMMTV-Wnt1mice, further underscoring
a requirement of TGIF for oncogenic Wnt signaling.INTRODUCTION
The Wnt signaling pathway regulates a plethora of important
cellular processes, such as specification of developmental fate,
proliferation, and differentiation. For example, Wnt signaling
coordinates proliferation and differentiation of stem/progenitor
cells in a variety of epithelial tissues, including the mammary
gland (Clevers and Nusse, 2012; MacDonald et al., 2009; Moon
et al., 2004). The broad theme that has emerged from extensive
examination of Wnt signaling is that any perturbation in this
circuitry disturbs tissue homeostasis, culminating in many dis-
eases, most prominent among them cancer. Broadly recognized
mechanisms behind Wnt-signaling hyperactivation in cancers
include mutations of pathway components and elevated auto-
crine signaling due to constitutive production of Wnt ligandsSignificance
Constitutive activation of Wnt signaling pathway is commonly
poorly understood. Here, we show that TGIF orchestrates a f
epithelial cells. This mechanism could be physiologically me
correlated with high Wnt signaling and a trend toward poor
TGIF for Wnt-driven mammary tumorigenesis in vivo. Thus, by
nent of the Wnt signaling pathway and documenting its impl
our findings shed light on the molecular mechanisms behind t(Clevers and Nusse, 2012; MacDonald et al., 2009; Moon et al.,
2004).
Wnt ligands initiate signaling by binding to two types of cell
surface receptors: the low-density lipoprotein receptor-related
proteins 5 and 6 (LRP5/LRP6) and the Frizzled (Fz) family of
serpentine proteins (Clevers and Nusse, 2012; MacDonald
et al., 2009; Moon et al., 2004). Over the past few years, there
have been tremendous advances in elucidating the molecular
mechanisms operating downstream of Wnt receptors to trigger
activation of canonical b-catenin signaling. The most prevalent
model implies that engagement of Wnt with the Fz/LRP5/LRP6
receptor complex provokes squelching of Axin1, which func-
tions in resting cells as a scaffold for the b-catenin destruction
complex, bringing together adenomatous polyposis coli (APC),
b-catenin, casein kinase 1 (CK1), glycogen synthase kinase 3observed in TNBC, but the underlying mechanisms remain
eed-forward network to sustain Wnt signaling in mammary
aningful to TNBC diagnosis, as elevated levels of TGIF are
survival. We also provide data showing the requirement of
demonstrating that TGIF functions as an essential compo-
ication in oncogenic Wnt signaling in the mammary gland,
he constitutive activation of Wnt signaling in TNBC.
Cancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc. 547
(GSK3), and ubiquitin E3 ligase bTRCP, among others. Within
this destruction complex, CK1 and GSK3 sequentially phos-
phorylate b-catenin, resulting in its recognition by bTRCP
and subsequent degradation by the proteasome. Upon ligand
binding, recruitment of Axin1 to LRP5/LRP6 leads to disas-
sembly of the destruction complex, resulting in increased
b-catenin accumulation (Clevers and Nusse, 2012; MacDonald
et al., 2009; Moon et al., 2004). An alternative model that
emerged recently shows that activation of Wnt signaling
does not merely affect assembly or composition of the
destruction complex but instead hinders ubiquitination and
clearance of b-catenin within an intact complex, leading to
saturation and inactivation of the destruction complex by
phosphorylated b-catenin (Li et al., 2012). Consequently, newly
synthesized, nonphosphorylated b-catenin escapes degrada-
tion by the saturated destruction complex and accumulates
in the nucleus. Irrespective of the molecular mechanisms by
which activated Wnt signaling achieves accumulation and
translocation of b-catenin into the nucleus, recruitment of
b-catenin to promoters of target genes via interaction with
enhancer factor/T cell family (TCF) transcription factors stands
as the main apparatus fulfilling the canonical Wnt transcrip-
tional program (Clevers and Nusse, 2012; MacDonald et al.,
2009; Moon et al., 2004).
Transforming growth-interacting factor (TGIF) belongs to
the superfamily of TALE homeodomain proteins that control
many biological processes, including embryonic development,
cell proliferation, and differentiation. Genetic ablation of Tgif1
in mice resulted in a large spectrum of phenotypes, including
placental defects, craniofacial abnormalities, and runting (Bar-
tholin et al., 2008; Taniguchi et al., 2012). Perhaps the most
extensively studied function of TGIF is suppression of transform-
ing growth factor beta (TGF-b) signaling, which has prominent
and widespread roles in cancer (Massague´, 2008; Seo et al.,
2006; Wotton et al., 1999). TGF-b initiates responses by binding
to and activating a cell surface receptor complex composed of
TbRI and TbRII serine threonine kinases, which then propagate
signals by phosphorylating the downstream effectors Smad2
and Smad3 (Feng and Derynck, 2005; Massague´, 2008). The
mechanism of TGIF-induced suppression of TGF-b signaling
has been primarily attributed to its ability to recruit a complex
of general transcriptional corepressors to DNA-bound Smad
transcription complexes (Wotton et al., 1999). However, our
recent findings argued that TGIF can also function through
mechanisms unrelated to transcriptional repression (Faresse
et al., 2008; Seo et al., 2004, 2006). Together, these observations
highlighted an ability of TGIF to antagonize TGF-b signaling in
multiple fashions.
Besides its ability to restrict the TGF-b tumor suppressor
network, there is evidence that TGIF may function as an onco-
genic protein in multiple settings, as exemplified by its ability to
confer a full malignant phenotype upon ectopic expression in
cell systems (Ettahar et al., 2013; Seo et al., 2006). Notwith-
standing these intriguing hints, it is becoming increasingly clear
that additional efforts should be put into discovery of molecular
mechanisms of TGIF-induced carcinogenesis, as they remain
mostly enigmatic. In this study, we sought to investigate whether
TGIF contributes to oncogenic Wnt signaling in the mammary
gland.548 Cancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc.RESULTS
TGIF Interacts with Axin1 and Axin2
To identify TGIF interacting partners, we undertook a yeast two-
hybrid approach using human TGIF as bait. Screening of a
human placental cDNA library repeatedly recovered Axin2, a
prominent antagonist of Wnt signaling (Behrens et al., 1998). To
determine whether TGIF binds Axin2 in mammalian cells, we
initially conducted coimmunoprecipitation experiments using
transfected HEK293T cells. As shown in Figure 1A, TGIF inter-
actedwith Axin2 at steady states, and exposure of cells to canon-
ical Wnt3a markedly increased this interaction. By contrast,
stimulation of cells with noncanonical Wnt5a failed to increase
this interaction (Figure S1A). A more in-depth examination of the
TGIF/Axin2 interaction using mammalian two-hybrid and coim-
munoprecipitation assays mapped the Axin2-binding domain to
the TGIF central region and the major TGIF-binding domain to
the Axin2 DIX domain (Figures 1B, 1C, S1B, and S1C). To deter-
mine whether this interaction is specific to Axin2, we conducted
yeast two-hybrid and coimmunoprecipitation experiments en-
compassing major components of Wnt signaling (i.e., LRP5/
LRP6, Dvl, Fz, Axin1, APC, b-catenin, TCF). The results revealed
that TGIF associated with Axin2 and its close homolog Axin1,
but not other components (Figures 1D and S1D and data not
shown). Similar to Axin2, the interaction of Axin1 with TGIF was
selectively increased by canonical Wnt3a (Figures 1D and S1D).
The interaction of TGIF with Axin1 or Axin2 is physiologically rele-
vant, as stimulation of MCF7 (human breast cancer) or HMLE (hu-
man immortalized mammary epithelial) cells with Wnt3a also
increased the interaction between endogenous TGIF and Axin1
or Axin2, as evidenced by reciprocal coimmunoprecipitation as-
says using specificantibodies (Figures1EandS1E). A timecourse
experiment usingHMLEcells showed thatWnt3a stimulation pro-
voked a rapid increase in the interaction of TGIF and Axin1 or
Axin2, which became apparent 15 min poststimulation and per-
sisted for at least 1 hr (Figure 1F). Under these experimental con-
ditions, Wnt3a had little or no effect on Axin2 expression, most
likely because this short-term stimulation was not sufficient to
induce expression of Axin2, similar to what is reported in the liter-
ature (Jho et al., 2002; Lustig et al., 2002). Quantification of the re-
sults indicates that 18% to 33% of Axin1 or Axin2 associate with
28% to 37% of TGIF (total pool) upon treatment of cells with
Wnt3a (Figures 1E and 1F). Together, these results revealed that
TGIF and Axin1 or Axin2 form physical complexes, which ap-
peared to increase upon activation of Wnt signaling.
TGIF Interferes with Axin1/Axin2 Nucleocytoplasmic
Shuttling
To begin unraveling the physiological role of TGIF in Wnt
signaling, we took advantage of the literature that TGIF localizes
mostly to the nucleus, whereas Axin2 shuttles between the cyto-
plasm and nucleus (Seo et al., 2006; Wotton et al., 1999; Yook
et al., 2006). We found that overexpressing TGIF enforced
Axin2 to accumulate in the nucleus (Figure 2A), which confirmed
their physical interaction and provided an initial indication that
TGIF might retain Axin2 away from the cytoplasm, where it coor-
dinates assembly of the b-catenin destruction complex. In agree-
ment with published data (Krieghoff et al., 2006), overexpressed
Axin2 localized mostly to the cytoplasm (Figure 2A), perhaps
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Figure 1. Interaction of TGIF with Axin1/Axin2
(A) HEK293T cells were transfected with Myc-Axin2 in the presence or absence of Flag-TGIF and treated with control or Wnt3a conditioned media (CM) for 1 hr.
Lysates were subjected to anti-Flag immunoprecipitation (IP) followed by immunoblotting (IB) with anti-Myc. In this and all the following experiments, expression
of proteins under investigation was determined by direct immunoblotting.
(B and C) HEK293T cells were transfected with pG5E1b-Luc together with Gal4-Axin2 and VP16-TGIF mutants (B) or Gal4-TGIF and VP16-Axin2 mutants (C).
Luciferase activity was measured, and data were expressed as mean ± SD of three independent samples.
(D) HEK293T cells were transfected with Flag-TGIF in the absence or presence of Myc-Axin1 and treated with control or Wnt3a CM for 1 hr. Cell lysates were
subjected to anti-Myc immunoprecipitation followed by immunoblotting with anti-Flag.
(E) MCF7 or HMLE cells were treated with control or Wnt3a CM for 1 hr, and cell lysates were immunoprecipitated with IgG or anti-TGIF before being analyzed by
immunoblotting using anti-Axin1, anti-Axin2, or anti-TGIF.
(F) HMLE cells were treated with Wnt3a CM for the indicated times, and cell lysates were immunoprecipitated with anti-TGIF before being analyzed by immu-
noblotting using anti-Axin1 or anti-Axin2.
See also Figure S1.because endogenous TGIF is a rate-limiting factor for Axin2 nu-
clear localization. Furthermore, we found that overexpressing
TGIF disrupted the interaction between Axin2 and b-catenin (Fig-
ure S2A), which is known to take place in the cytoplasm.We also
conducted immunofluorescence and cell-fractionation assays
using mouse embryonic fibroblasts (MEFs) from wild-type or
Tgif1/ mice and found that Tgif1 deletion culminated in re-
distribution of endogenous Axin2 into the cytoplasm as well as
increased association of Axin2 with b-catenin (Figures 2B–2D
and S2B). These results are not restricted to Axin2, as TGIF defi-
ciency was also associated with redistribution of endogenous
Axin1 into the cytoplasm and concomitant association with
b-catenin (Figures 2C and 2D). As a control, Tgif1 deletion did
not affect the interaction of b-cateninwith E-cadherin (Figure 2D),
indicating that TGIF specifically targeted the b-catenin pool that
is dedicated to the destruction complex. Mechanistically, TGIF
appeared to engageAxin1 andAxin2 in a complex that prevented
their association with the nuclear export receptor CRM1 (Congand Varmus, 2004; Yook et al., 2006), since deletion of Tgif1 re-
sulted in increased association of endogenous CRM1 and
Axin1 or Axin2 (Figure 2E). A similar conclusion could be drawn
from an in vitro reconstitution experiment using purified proteins
(Figure S2C), corroborating the ability of TGIF to block access of
CRM1 for association with Axin1 or Axin2.
TGIF Promotes b-Catenin Abundance
The results outlined so far suggest that TGIF associates with and
diverts Axin1 and Axin2 from the transport machinery that coor-
dinates their nuclear export and thus prevents assembly of the
destruction complex. In so doing, TGIF could conceivably hinder
b-catenin phosphorylation by GSK3b and its subsequent degra-
dation by bTRCP. We obtained several lines of evidence sup-
porting this hypothesis. Tgif1/ MEFs displayed increased
phosphorylation of b-catenin at the GSK3b phosphorylation
sites Ser33/Ser37 as compared to wild-type MEFs (Figure 3A).
Expression of TGIF increased the abundance of wild-typeCancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc. 549
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Figure 2. TGIF Interferes with the Nucleocy-
toplasmic Transit of Axin1/Axin2
(A) COS-7 cells were transfected with Flag-Axin2
and GFP-TGIF and immunostained with anti-Flag
and DAPI. Scale bars, 100 mM.
(B) Wild-type or Tgif1/ MEFs were immuno-
stained with anti-Axin2 and DAPI. Scale bars,
100 mM.
(C) Cytoplasmic or nuclear fractions fromwild-type
or Tgif1/ MEFs were immunoblotted with anti-
Axin1 or anti-Axin2. Purity of the nuclear and
cytoplasmic fractions was verified by immuno-
blotting using anti-Lamin B or anti-a-tubulin.
(D and E) Lysates from wild-type or Tgif1/MEFs
were immunoprecipitatedwith anti-b-catenin (D) or
anti-CRM1 (E) and analyzed by immunoblotting
with the indicated antibodies.
See also Figure S2.b-catenin but was ineffective against b-catenin.S33Y, a degra-
dation-resistant mutant (Figure 3B). Ectopic expression of TGIF
inhibited the interaction between b-catenin and bTRCP (Fig-
ure 3C). Induction of TGIF expression in MCF7 cells harboring
a doxycycline-inducible TGIF increased the abundance of
endogenous b-catenin, concurring with decreased interaction
of b-catenin with bTRCP (Figure 3D). Similar experiments using
MEFs showed that Tgif1 ablation decreased the abundance of
b-catenin, concurring with increased association of b-catenin
with bTRCP (Figure 3A). However, Tgif1 deletion did not affect
the abundance of b-catenin mRNA (Figure S3A). Stimulation of
Tgif1/ MEFs with Wnt3a failed to promote b-catenin accumu-
lation as compared to wild-type MEFs (Figure 3E). Exposure of
Tgif1/ MEFs to the proteasome inhibitor MG132 for 12 hr
increased the b-catenin abundance to the level detected in
wild-type MEFs (Figure 3F). Analysis of mammary glands from
Tgif1 knockout mice showed that TGIF deficiency decreased
the abundance of total and active (nonphosphorylated) b-catenin
without altering the accumulation of its mRNA (Figures 3G, 3H,
and S3B). Extending our analysis to human breast tissue, we
noticed a correlation between the expression of TGIF and b-cat-
enin that is mainly confined to the whole epithelial duct structure
(Figure S3C); we return to this observation later (Figure 5F).
Collectively, these findings strongly suggest that a physiological
function of TGIF is to divert Axin1 and Axin2 from the b-catenin
destruction complex, thereby leading to b-catenin accrual.
TGIF as a Mediator of Wnt Signaling
Owing to its ability to promote b-catenin stability, one would sur-
mise that TGIF functions as a key component of Wnt signaling. In
fact, expression of TGIF enhanced the sensitivity of MCF7 and
HMLE cells to Wnt3a-induced TOPFlash (Figure S4A), a surro-
gate readout of Wnt signaling (Korinek et al., 1997). Likewise,550 Cancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc.expression of TGIF synergized with b-cat-
enin in eliciting increased TOPFlash activ-
ity (Figures S4B and S4C), in line with the
hypothesized function of TGIF to foster
b-catenin stability through nuclear seq-
uestration of Axin1 and Axin2. In further
support of this notion, expression ofAxin1 or Axin2 blunted the synergism between TGIF and b-cate-
nin on TOPFlash; yet this antagonistic effect was reversed by
raising the levels of TGIF (Figure S4B). In an alternative
approach, expression of TGIFDAxin2 (TGIFD148–177), which
no longer interacted with Axin2 (Figures 1B and S1B), was void
of any effect on b-catenin-induced TOPFlash (Figure S4C).
Finally, expression of TGIF failed to enhance b-catenin.S33Y-
induced TOPFlash as compared to wild-type b-catenin (Fig-
ure S4C), providing further support to the notion that TGIF con-
tributes to Wnt signaling by fostering b-catenin stability.
In our attempts to validate this scenario under physiological
conditions, we found that depleting TGIF in MCF7 or HMLE cells
suppressed Wnt3a-induced expression of six endogenous Wnt
target genes:CCND1,MYC, LEF1,DKK1,AXIN2, and LGR5 (Fig-
ures 4A and 4B). This inhibitory effect was not due to changes in
cell proliferation, since depletion of TGIF did not affect progres-
sion through the cell cycle under these experimental conditions
(Figure S4D). Similar gene expression profiles and cell cycle pro-
gression results were obtained using MEFs from wild-type and
Tgif1/ mice (Figures S4E–S4G). To further substantiate our
findings in vivo, we crossed Tgif1 knockout mice with MMTV-
Wnt1mice, which harbor constitutive Wnt signaling in the mam-
mary gland (Tsukamoto et al., 1988). Using eight mice in each
group, we found that Tgif1 deletion markedly blocked Wnt1-
induced gene expression (Figures 4C and 4D). During the course
of these in vivo analyses, we generated two mammary cancer
cell lines (MWT23 and MWT37) from MMTV-Wnt1 mice bearing
a floxed Tgif1 allele along with a tamoxifen-inducible Cre recom-
binase (MMTV-Wnt1;Tgif1fl/fl;CAG-Cre-ERT2) (Shen and Walsh,
2005). We found that Tgif1 deletion in MWT23 or MWT37 cells
challenged with tamoxifen (Tam) decreased expression of
Ccnd1, Myc, Lef1, Dkk1, Axin2, and Lgr5 (Figures 4E, 4F, S4H,
and S4I). This effect is likely due to Tgif1 deletion, as add-back
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Figure 3. TGIF Interferes with b-Catenin Degradation
(A) Lysates from Tgif1+/+ or Tgif1/MEFs were immunoprecipitated with IgG or anti-b-catenin and analyzed by immunoblotting using the indicated antibodies.
(B) MCF7 cells were transfected with HA-b-catenin or HA-b-catenin.S33Y in the absence or presence of Flag-TGIF, and cell lysates were immunoblotted with
anti-HA or anti-Flag.
(C) HEK293T cells were transfected with Flag-b-catenin together with Myc-bTRCP and increasing amounts of Flag-TGIF. Association of b-catenin with bTRCP
was analyzed by blotting anti-Myc immunoprecipitates with anti-Flag.
(D) MCF7-Dox-Myc-TGIF cells were cultured with or without doxycycline (Dox) for 48 hr. Association of b-catenin with bTRCP was determined by blotting anti-
bTRCP immunoprecipitates with anti-b-catenin.
(E) Tgif1+/+ or Tgif1/MEFs were cultured with control or Wnt3a CM for the indicated times, and lysates were immunoblotted with anti-b-catenin, anti-Axin2, or
anti-TGIF.
(F) Tgif1+/+ or Tgif1/ MEFs were treated with vehicle or MG132 for 12 hr, and cell lysates were subject to immunoblotting using anti-b-catenin.
(G) Expression of b-catenin was analyzed using extracts from mouse mammary glands with the indicated genotypes.
(H) Analysis of active (nonphosphorylated) b-catenin levels in mammary glands from Tgif1+/+ or Tgif1/ mice by immunohistochemistry. The percentage of
stained cells in at least 20 independent fields is indicated. The line inside the box showsmedian percentage. The top and bottom of the box represent upper (third)
and lower (first) quartile percentages, respectively. The lines above and below the box show maximum and minimum percentages, respectively. Scale bars,
50 mM.
See also Figure S3.of TGIF in these cells restored Wnt signaling to levels similar to
those seen in the parental MWT23 andMWT37 cell lines (Figures
4E, 4F, S4H, and S4I). Together, these data strongly suggest that
TGIF functions as a key component of Wnt signaling, most likely
by restrictingmovement of Axin1 or Axin2 into the cytoplasm and
thereby enforcing b-catenin accumulation.
TGIF Is a Wnt Target Gene
We noticed in our earlier experiments that Wnt3a stimulation re-
sulted in increased accumulation of the TGIF protein in MEFs,MCF7, and HMLE cells (Figures 3E and 4B). We confirmed this
observation in vivo by demonstrating increased TGIF abundance
in two mouse models of activated Wnt signaling: MMTV-Wnt1
and Dkk1+/ (Figure 5A) (Mukhopadhyay et al., 2001; Tsukamoto
et al., 1988). Stimulation of MEFs with Wnt3a or expression
of Wnt1 in MMTV-Wnt1 mice induced accumulation of Tgif1
mRNA (Figures S5A and S5B). A ChIP experiment demonstrated
that stimulation of HMLE cells with Wnt3a increased binding of
b-catenin or TCF4 to a TCF-binding element in the TGIF1 pro-
moter (Figure 5B). Consistent with this finding, Wnt signalingCancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc. 551
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Figure 4. TGIF Promotes Wnt Signaling
(A and B) MCF7 or HMLE cells stably expressing control (sh.Luc) or TGIF (sh.TGIF) shRNAs were cultured with control or Wnt3a CM for 24 hr. Expression of Wnt
target genes was analyzed by qRT-PCR (A), and the expression of CyclinD1 or TGIF was determined by immunoblotting (B).
(C and D) Expression of Wnt target genes in the mammary glands of mice with the indicated genotypes (eight in each group) was analyzed by qRT-PCR (C), and
the expression of CyclinD1 was assessed by immunoblotting (D).
(E and F) MWT23 cells stably expressing empty vector or TGIF were treated with vehicle or tamoxifen (Tam) for 5 days, expression of Wnt target genes was
analyzed by qRT-PCR (E), and the expression of CyclinD1 or TGIF was determined by immunoblotting (F).
Results in (A), (C), and (E) are expressed as mean ± SD of three independent samples.
See also Figure S4.
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activation in HMLE cells expressing a Dox-inducible b-cate-
nin.S33Y increased the expression of the TGIF protein and
mRNA (Figure 5C). Conversely, suppressing Wnt signaling in
HMLE cells expressing an inducible-dominant negative form of
TCF4 (DN-TCF4) (Korinek et al., 1997) blunted Wnt3a-induced
accumulation of the TGIF protein and mRNA (Figure 5D). Addi-
tionally, depleting b-catenin by two independent Dox-inducible
shRNAs in the human mammary cancer cell line MDA-MB231,
which harbors constitutive autocrine Wnt signaling (Bafico
et al., 2004), was associated with decreased expression of the
TGIF protein and mRNA (Figures S5C and S5D). Finally, we de-
tected a significant decrease in TGIF expression in mice bearing
conditional deletion of b-catenin (Figure 5A) (Tan et al., 2008),
further emphasizing Tgif1 as a direct Wnt target gene.
The aforementioned findings suggest that TGIF orchestrates a
feed-forward loop to propagate Wnt signaling once activated.
To further explore the involvement of TGIF in Wnt signaling under
normal homeostatic conditions, we assessed the long-term ef-
fects of Wnt signaling on TGIF expression in MCF7 cells. In a
time-course experiment, Wnt3a stimulation induced a robust in-
crease in the TGIF protein level after 24 hr, but this induction grad-
ually declined, returning to the basal level at 96 hr (Figure 5E).
Similar results were obtained when the expression of the TGIF1
mRNA was analyzed (Figure S5E). During the course of these ex-
periments, we also evaluated the expression of CNND1, MYC,
DKK1, and LEF1 and observed similar transient responses to
Wnt signaling (Figure S5E). In light of our earlier findings that
TGIF promotes Wnt signaling, it is tempting to suggest that the
decline in TGIF expression drivenbyprolongedWnt3a stimulation
might enable downregulation of Wnt signaling to an extent that is
suitable for maintaining normal cell function and homeostasis.
Expression of TGIF Recapitulates Activation of Wnt
Signaling in TNBC
To further investigated the physiological interplay between TGIF
andWnt signaling, we examined whether TGIF expression in hu-
man cancer correlated with activation of Wnt signaling, focusing
on TNBC, which has been shown to display recurrent hyperacti-
vation of Wnt/b-catenin signaling (Cowin et al., 2005). We initially
interrogated the Cancer Genome Atlas (TCGA) breast cancer
database and found that TGIF expression increased with tumor
stages when compared to normal tissues (Figure S5F). To con-
firm these results, we conducted immunohistochemistry staining
using human tissue microarrays (TMAs) containing 173 normal
and breast cancer samples. Relative to adjacent normal tissues,
an increase in TGIF expression was detected in tumors at any
stages examined, although the amplitude of such change tends
to increase in more advanced stages, similar to our TCGA anal-
ysis (Figures 5F, S5F, and S5G). Intriguingly, we detected a cor-
relation between the expression of TGIF and b-catenin in TNBC
as compared to other breast cancer subtypes (Figure 5F), indi-
cating that TGIF overexpression is associated with constitutive
activation of b-catenin in TNBC, which is in line with recurrent
activation of Wnt signaling in TNBC (King et al., 2012). To deter-
mine whether TGIF overexpression per se could trigger con-
stitutive Wnt signaling, we analyzed two derivatives of MCF7
harboring a Dox-inducible TGIF. Inducing TGIF expression
resulted in increased b-catenin protein without affecting its
mRNA level (Figures 5G and S5H), supporting our concept thatTGIF promotes b-catenin accumulation by preventing its clear-
ance by the destruction complex. Of note, inducing TGIF ex-
pression also elicited increased expression of several Wnt
target genes (Figure S5H), confirming that TGIF overexpression
is sufficient to trigger constitutive activation of Wnt/b-catenin
signaling in human breast cancer cells.
To cross-validate our patient-oriented findings, we analyzed
four published gene expression datasets of human breast can-
cers (Miller et al., 2005; Pawitan et al., 2005; Wang et al., 2005;
Yu et al., 2008) using combined expression of the Wnt target
genes CCND1, MYC, DKK1, LEF1, AXIN2, and LGR5 as a mini-
mal signature. Here again, we found a strong correlation be-
tween the expression of TGIF1 and activation of Wnt signaling
in all datasets examined (Figure S5I).
Finally, we investigated whether the TGIF expression level
correlated with the outcome of patients with TNBC. For this we
made use of a dataset containing exclusively TNBC, which
enabled us to generate two groups with ‘‘high’’ and ‘‘low’’ TGIF
expression and divide these two groups into subtypes of
TNBC (see Supplemental Experimental Procedures). Elevated
expression of TGIF trended toward relapse and patient death
(Figures 5H and S5J). Of note, this trend holds true for all
TNBC subtypes, including mesenchymal, basal-like 1, basal-
like 2, immunomodulatory, mesenchymal stem-like, and luminal
androgen receptor (data not shown).
TGIF Contributes to Wnt-Induced Mammary
Tumorigenesis
Having established a link between TGIF and Wnt signaling in
TNBC, we investigated whether expression of TGIF affected
growth of mammary tumors harboring hyperactive Wnt signaling
and found that Tgif1 ablation abolished Wnt1-induced tumori-
genesis (Figures 6A and S6A). During the observation period,
all 25 MMTV-Wnt1 mice developed tumors, whereas none of
the 20 MMTV-Wnt1;Tgif1/ did (Figure 6B). Interestingly, only
5 out of 23 MMTV-Wnt1;Tgif1+/ mice developed one tumor
each that became palpable markedly later (Figures 6C and
S6B), indicating that the Tgif1 gene dosage is sufficient to affect
tumor fate. Of note, Tgif1 deletion in the wild-type background
did not affect normal mammary development or architecture,
supporting the hypothesis that TGIF deficiency hampers mam-
mary tumor formation in MMTV-Wnt1 mice by impeding onco-
genic Wnt signaling (Figure 6D and data not shown). To further
appreciate the impact of TGIF on Wnt1-induced tumorigenesis,
we investigated whether Tgif1 ablation could override the hyper-
plasic mammary phenotype typically seen inMMVT-Wnt1mice.
Vis-a`-vis the wild-type counterpart,MMTV-Wnt1mice exhibited
widespread hyperplasia characterized by extensive ductal side
branching and aberrant lobular structures (Figure 6D), as previ-
ously described (Tsukamoto et al., 1988). Tgif1 ablation in
MMTV-Wnt1 mice blocked the development of the hyperplasic
phenotype, yielding mammary gland with almost normal
morphogenesis (Figure 6D). Further histopathological analyses
documented that allMMTV-Wnt1;Tgif1+/+mice developed lobu-
loalveolar adenocarcinoma, whereas all MMTV-Wnt1;Tgif1/
mice remained free of such tumor (Figure 6E).
To determine whether overexpression of TGIF could pheno-
copy the mammary tumor phenotype in MMTV1-Wnt1 mice,
we used our MWT23 andMW37 cell lines, which develop tumorsCancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc. 553
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Figure 5. TGIF Is a Wnt Target Gene
(A) Expression of TGIF or b-catenin was assessed by immunoblotting using extracts from mammary glands of MMTV-Wnt1 or Dkk1 mice or liver from Ctnnb1
conditional knockout.
(B) HMLE cells were left untreated or treated with control or Wnt3a CM for 24 hr, and chromatin was immunoprecipitated with anti-b-catenin, anti-TCF4, or IgG.
Bound chromatin (in control cells) was amplified by PCR and analyzed by 2% agarose gel (left). Bound chromatin in control or Wnt3a-treated cells was analyzed
by qRT-PCR.
(C and D) HMLE-Dox-HA-b-catenin (C) or HMLE-Dox-Myc-DN-TCF4 (D) cells were treated with or without Dox for 48 hr before being cultured with or without
Wnt3a CM for 16 hr. Expression of TGIF protein and mRNA was measured by immunoblotting and qRT-PCR, respectively.
(E) MCF7 cells were left untreated or were treated with Wnt3a for different times, and expression of TGIF was assessed by immunoblotting.
(F) Expression of TGIF and b-catenin in tissuemicroarrays including 173 human breast cancer sampleswas analyzed by immunohistochemistry. The percentages
of samples with high expression of TGIF and b-catenin in TNBC and non-TNBC subtypes are shown. Scale bars, 50 mM.
(G) MCF7 cells were stably transfected with doxycycline-inducible TGIF (two independent populations) or empty vector and treated with or without Dox for 48 hr.
Expression of b-catenin or TGIF was determined by immunoblotting.
(legend continued on next page)
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Figure 6. Tgif1 Deletion Blocks Wnt1-Induced Mammary Tumors
(A) Tgif1+/+, MMTV-Wnt1;Tgif1+/+, or MMTV-Wnt1;Tgif1/ mice were photographed 3 weeks after the tumors became palpable.
(B and C) MMTV-Wnt1 mice with Tgif1+/+, Tgif1+/, or Tgif1/ genotypes were palpated twice weekly from puberty onward for 60 weeks, and dates of tumor
incidence were recorded (B). For comparison, tumor volumes at sacrifice were shown (C).
(D) Whole-mount staining of mammary glands from 4-month-old virgin mice with the indicated genotypes.
(E) H&E staining of mammary glands from mice with the indicated genotypes three weeks after tumor formation. Scale bars, 500 mM for (D) and 200 mM for (E).
See also Figure S6.upon transplantation into mammary fat pad of syngeneic mice.
To generate cells overexpressing TGIF, we used a Flp-In-depen-
dent recombination system to achieve integration of one or two
copies of TGIF in MWT23 andMWT37 cells at the same genomic
loci, thereby avoiding any clonal heterogeneity that could arise
owing to random integration of variable copy numbers or
silencing after integration within the same cell population. West-
ern blot analysis showed that integration of a single copy yielded
an expression level approaching that of endogenous TGIF,
whereas integration of two copies yielded nearly twice the
endogenous level (Figure 7A). In transplantation assays, deletion
of endogenous Tgif1 (by Tam stimulation) suppressedmammary
tumor formation, and this effect was reversed by expression of a
single copy of TGIF (Figure 7B). More importantly, MWT23 and
MWT37 cells harboring two TGIF copies exhibited an increase(H) Kaplan-Meier graph representing the probability of cumulative recurrence-fre
high (255).
Results in (B)–(D) (right) are expressed as mean ± SD of three independent samp
See also Figure S5.in mammary tumor growth as compared to the parental cells
(Figure 7B), providing strong evidence that overexpression of
TGIF promotes mammary tumor pathogenesis.
To investigate whether TGIF promotes mammary tumor for-
mation by a mechanism dependent on its ability to interfere
with assembly of the b-catenin destruction complex, we per-
formed in vivo epistasis experiments between TGIF and Axin1/
Axin2 using MWT23 and MWT37 cells. The results showed that
Tgif1 deletion was ineffective in suppressing tumor growth of
MWT23 and MWT37 cells stably expressing two different sets
of shRNAs targeting Axin1 and Axin2, when compared to cells
stably expressing control shRNA (Figures 7C and 7D). Accompa-
nying biochemical and gene expression profiling experiments
demonstrated that Tgif1 deletion decreased the abundance of
the b-catenin protein and Ccnd1, Myc, Lef1, and Dkk1 mRNAse survival in TNBC patients according to the TGIF expression, low (128) versus
les from representative experiments performed at least three times.
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Figure 7. TGIF Promotes Mammary Tumors by a Mechanism Dependent on Its Ability to Antagonize Axin1/Axin2
(A) Flip-In MWT23 or MWT37 cells carrying one or two copies of TGIF were treated with vehicle or Tam for 5 days. Expression of TGIF was assessed by
immunoblotting.
(B) Cells (as in A,105) were implanted into mammary fat pad of FVB mice, and tumor volumes were measured at the indicated times.
(C) MWT23 cells stably expressing the indicated shRNAs were treated with vehicle or Tam for 5 days. Expression of Axin1, Axin2, or b-catenin was assessed by
immunoblotting.
(D) Cells (as in C, 5 3 105) were transplanted into mammary fat pad of FVB mice, and tumor volumes were measured at the indicated times.
Results in (B) and (D) are expressed as mean ± SD of measurements obtained with six animals in each group.
See also Figure S7.in control cells but failed to do so in cells depleted of Axin1 and
Axin2 (Figures 7C and S7). Collectively, these results suggest
TGIF contributes to Wnt1-induced mammary tumor formation
by impeding the ability of Axin1/Axin2 to coordinate b-catenin
degradation.
TGIF Promotes Wnt Signaling by a Mechanism
Independent of TGF-b Signaling
In light of its ability to restrict TGF-b cytostatic signaling (Seo
et al., 2006; Wotton et al., 1999), we wondered whether Tgif1
deletion could restrain Wnt1-induced mammary tumor patho-
genesis merely by implementing sustained TGF-b signaling
rather than suppressing Wnt signaling. However, under condi-556 Cancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc.tions inwhich sixmock-treatedMMTV-Wnt1;Tgif1+/+micedevel-
oped tumors, sixMMTV-Wnt1;Tgif1/mice treated with a TGF-
b receptor inhibitor (SB-505124) were still free of tumors, despite
the apparent blockade in TGF-b signaling, as evidenced by the
impaired phosphorylation of Smad2 (Figure S8A). To confirm
this result, we conducted transplantation experiments using
TGIF-deficientMWT23orMWT37cells stably expressing adomi-
nant negative form of TbRII (DN-TbRII) or b-catenin.S33Y as con-
trols. In contrast to b-catenin.S33Y, expression of DN-TbRII
failed to rescue mammary tumor formation (Figure 8A). Rather,
we noticed that expressing DN-TbRII exacerbated the decrease
in mammary tumor formation, which is in agreement with previ-
ous observations that activation of TGF-b signaling promotes
AB
C
Figure 8. TGIF Promotes Wnt1-Induced Mammary Tumor Formation by a TGF-b-Independent Mechanism
(A and B)MWT23 orMWT37 cells stably expressing empty vector, HA-DN-TbRII, or HA-b-catenin.S33Y (A) or empty vector, HA-TGIF, or HA-TGIFDAxin2 (B) were
treated with vehicle or Tam for 5 days. Expression of transfected proteins was determined by immunoblotting (left). Cells (5 3 105) were transplanted into
mammary fat pad of FVB mice, and tumor volumes were measured at the indicated times (right).
(C) A model depicting the link of TGIF to the Wnt signaling network.
Results in (A) and (B) are expressed as mean ± SD of measurements obtained with six animals in each group.
See also Figure S8.MMTV-Wnt1-induced mammary tumorigenesis (Labbe´ et al.,
2007). In control experiments, expression of DN-TbRII blocked
Smad2 phosphorylation, attesting to the functionality of our
design approach (Figure S8B).To further investigate the relative importance of regulating the
TGF-b signaling and theWnt signaling, we used the TGIF mutant
TGIFDAxin2, which does not interact with Axin2 or activate Wnt
signaling but inhibits TGF-b signaling (Seo et al., 2006) (FiguresCancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc. 557
S8C and S8D). In reconstitution experiments using MWT23 or
MWT37 cells, expression of wild-type TGIF restored Wnt1-
induced mammary tumor formation, whereas expression of
TGIFDAxin2 was ineffective (Figure 8B). We conclude that
TGIF contributes to Wnt-induced gene expression and mam-
mary tumor formation by a mechanism dependent on its ability
to foster Wnt signaling rather than suppress TGF-b signaling.
DISCUSSION
A key regulatory step in Wnt signaling is the regulation of b-cat-
enin abundance by a cytoplasmic destruction complex com-
posed of Axin1 or Axin2, APC, GSK3, CK1, and bTRCP. Axin1
and Axin2 function as scaffolding platforms for this b-catenin
destruction complex, coordinating consecutive phosphoryla-
tions of b-catenin by CK1 and GSK3 that marks b-catenin for
ubiquitination by bTRCP, leading to b-catenin degradation by
the proteasome (Clevers and Nusse, 2012; MacDonald et al.,
2009; Moon et al., 2004). Because Axin1 and Axin2 are deemed
to be the rate-limiting constituents of the destruction complex,
the vast majority of the destruction-complex-oriented studies
were devoted to delineating the mechanisms governing the
availability or abundance or both of Axin1 and Axin2 in the cyto-
plasm, including sequestration by LRP5/LRP6, ADP-ribosylation
by tankyrase, or phosphorylation by GSK3 (Huang et al., 2009;
Kim et al., 2013; Mao et al., 2001). However, since Axin1 and
Axin2 shuttle between the cytoplasm and nucleus (Cong and
Varmus, 2004; Yook et al., 2006), one would envision that other
mechanisms might also impose a control over assembly of the
destruction complex. Our present study reveals an interaction
between TGIF and Axin1 or Axin2 in the nucleus that seems to
play an important role in Wnt signaling.
Our results clearly demonstrate that TGIF sequesters Axin1 or
Axin2 into the nucleus, thereby interfering with the assembly of
the b-catenin destruction complex and leading to b-catenin
accrual. Consistent with this observation, TGIF is essential for
activation of the Wnt transcriptional program both in vitro and
in vivo. Intriguingly, activation of Wnt signaling induces expres-
sion of TGIF, suggesting that TGIF might function to coordinate
a feed-forward loop that ensures effective integration of Wnt
signaling. Congruent with our findings, Tgif1 knockout mice
display phenotypes similar to those observed in Wnt2 knockout
mice, including abnormal placental defects, premature death,
and runting (Bartholin et al., 2008; Monkley et al., 1996). Like-
wise, both Tgif1 and Axin2 knockout mice display craniofacial
abnormalities (Taniguchi et al., 2012; Yu et al., 2005), further sup-
porting the link of TGIF to canonical Wnt signaling.
On the basis of our findings, we propose a model in which
TGIF plays active roles in both the absence and presence of
Wnt signaling by limiting the cytosolic pools of Axin1 or Axin2
that are typically dedicated to the assembly of the b-catenin
destruction complex (Figure 8C). Taking into consideration the
current prevailing models of Wnt signaling (Clevers and Nusse,
2012; Li et al., 2012; MacDonald et al., 2009; Moon et al.,
2004), we speculated that this antagonistic mechanism might
function to fine tune the destruction complex assembly to enable
b-catenin to accumulate to an extent that ensures integration of
suitable levels of endogenous Wnt signaling needed to maintain
normal cell function and tissue homeostasis. Alternatively, TGIF558 Cancer Cell 27, 547–560, April 13, 2015 ª2015 Elsevier Inc.could function at steady-state conditions to facilitate saturation
of the destruction complex by newly synthesized b-catenin,
which in turn enables cells to respond efficiently to an acute acti-
vation of Wnt signaling. Finally, it is also conceivable that TGIF
might function to implement sustained Wnt signaling depending
on the pathophysiological setting, cell behaviors, or alterations in
components of the destruction complex other than Axin1 or
Axin2. As such, the molecular framework that we propose will
likely contribute to the elucidation of mechanistic paradigms of
the destruction complex irrespective of its fate (i.e., saturation,
disassembly) subsequent to activation of Wnt signaling.
Our study also underscores an ability of TGIF to promote
Wnt-driven mammary tumor pathogenesis. Interestingly, both
pharmacological and genetic experiments demonstrate that
TGIF promotes mammary hyperplasia in MMTV-Wnt1 mice by
activating Wnt signaling rather than repressing TGF-b signaling.
Recent xenograft studies showed that activation of Wnt sig-
naling can either promote growth or trigger squamous differenti-
ation of human breast cancer cells depending on the cellular
context (Green et al., 2013). Since deletion of Tgif1 in MMTV-
Wnt1mice was effective in blocking mammary tumor, one would
suggest that TGIF might function as a key component of onco-
genic Wnt signaling, although we cannot rule out the possibility
that TGIF also contributes to Wnt-driven squamous cell differen-
tiation under other conditions. Further studies will be required to
clarify this issue.
Although our analyses revealed increased TGIF expression in
TNBC, we did not find TGIF1 amplification. Moreover, we found
only one missense mutation (substitution R228 to I) in TGIF1 in
the Catalogue Of Somatic Mutations In Cancer (COSMIC) data-
base, further ruling out the existence of significant genetic alter-
ations that could account for the deregulation of TGIF expression
in this malignancy. Recently, we reported that the gene encoding
PHRF1, an E3 ubiquitin ligase that drives TGIF degradation, was
deleted in 21.6% of human breast cancers (Ettahar et al., 2013).
On the basis of this observation, it is appealing to speculate that
recurrent deletion of PHRF1 in breast cancer could represent
one potential mechanism that governs TGIF accumulation. How-
ever, initial analysis of datasets available in public databases
failed to reveal any significant correlation between PHRF1 dele-
tion and TGIF1 gene expression in TNBC or other breast cancer
subtypes, suggesting that accumulation of TGIF may involve
additional mechanisms. Thus, an in-depth understanding of
the molecular mechanisms behind the increased TGIF expres-
sion in TNBC will require more extensive and comprehensive
investigations.
From a translational perspective, we validated the relationship
between TGIF and Wnt signaling in human breast cancer.
Notably, we found a correlation between the TGIF expression
levels and activation of Wnt signaling in breast cancers (Miller
et al., 2005; Pawitan et al., 2005; Wang et al., 2005; Yu et al.,
2008). Moreover, our analyses revealed that TGIF and b-catenin
are overexpressed in a high proportion of TNBC samples as
compared to normal tissue or other breast cancer subtypes.
Finally, we detected a trend toward a poorer outcome for the
TNBC with a higher expression of TGIF. Besides these findings
with potential prognostic impact, our data also highlighted a
requirement of TGIF for Wnt-driven mammary tumor formation
in vivo, giving rise to another framework for future investigation
of TGIF as a potential target for anticancer drug design to curb
aberrant Wnt signaling in TNBC and possibly other malignancies
harboring hyperactive Wnt signaling.
In summary, our data unveil a functional interplay between
TGIF and Axin1 or Axin2 that appears to evolve into a feed-for-
ward loop to sustain Wnt signaling. Since TGIF appeared to
contribute toWnt-inducedmammary hyperplasia, this amplifica-
tion mechanism could conceptually deepen oncogenic Wnt
signaling capabilities to an extent that ultimately compromises
tissue homeostasis, culminating in neoplasia. Thus, by identi-
fying TGIF as an essential component of Wnt signaling, our find-
ings provide important insights into mechanistic paradigms of
aberrant Wnt signaling in human malignancies.
EXPERIMENTAL PROCEDURES
Yeast Two-Hybrid Screen
The yeast two-hybrid screen was performed using a fragment of human
TGIF (amino acid 1-192) as bait, essentially as previously described (Col-
land et al., 2004). The TGIF fragment was obtained by PCR and cloned
into the pB27 plasmid as a C-terminal fusion to LexA. Subsequently, the
bait construct was transformed into the L40DGAL4 yeast strain. As a
prey, a random-primed cDNA library from human placenta poly(A+)-RNA
was constructed into pP6. The library was transformed into the Y187 strain
and mated to the bait strain. The screening conditions were adapted in or-
der to test a minimum of 50 million interactions. The selectivity of the His3
reporter was modulated with 3-aminotriazole (3AT). His+ colonies were
selected on a medium lacking tryptophan, leucine, and histidine, and the
prey fragments were sequenced. Axin2 was one of the preys that exhibited
strong and specific binding to TGIF.
Cell Lines and Culture
All cell lines were cultured in DMEM supplemented with 10% fetal calf serum
(FCS) and antibiotics. MCF7 and HMLE cells were chosen to study the link of
TGIF toWnt signaling because they were found to express detectable levels of
components of this pathway that were investigated in this study.
Mice
MMTV-Wnt1 and CAG-Cre.ERT2 mice were obtained from the Jackson
Laboratory. Tgif1fl/fl, Tgif1+/, Dkk1+/, and liver-specific Ctnnb1 knockout
(Ctnnb1fl/fl;Foxa3.Cre) mice were described previously (Mukhopadhyay
et al., 2001; Shen and Walsh, 2005; Tan et al., 2008). Experimental animals
were kept as virgins throughout the study.
For transplantation experiments, MWT23 and MWT37 cells were injected
into mammary fat pad of 8-week-old FVB mice, and tumor volumes were
measured every week. All animal studies were approved by the Institutional
Animal Care and Use Committee (IACUC) of Harvard Medical School or Uni-
versity of Mississippi Medical Center.
Immunoprecipitation and Immunoblotting
Cell extracts were prepared as previously described (Demange et al., 2009; Et-
tahar et al., 2013) and subjected to immunoprecipitation with the appropriate
antibody for 2 hr, followed by adsorption to Dynabeads Protein G (Invitrogen)
for 1 hr. The samples were then analyzed by SDS-polyacrylamide gel and
immunoblotting. We used 500 to 1,000 mg and 50 to 100 mg of total proteins
for immunoprecipitation and immunoblotting, respectively, depending on the
cell line. Quantification of the association of Axin1/Axin2 with TGIF was deter-
mined by scanning laser densitometry.
Immunofluorescence and Immunohistochemistry
Cells were fixed in 4% paraformaldehyde, permeabilized in PBS containing
0.1% Triton X-100, and incubated with the primary antibodies or IgG-matched
isotype control antibody at room temperature for 2 hr. Then cells were incu-
bated with the secondary antibodies conjugated to Alexa-Fluor 568 or Alex-
Fluor 448 and stained with DAPI. Slides were viewed on a fluorescence
microscope.For analysis of mouse mammary glands by immunohistochemistry, tissues
were fixed in 10% formalin and embedded in paraffin. For human TMA anal-
ysis, we used slides containing sections from paraffin-embedded normal or
breast cancer samples. Mouse or human sections were deparaffinized with
xylene and rehydrated in a graded series of ethanol. Antigen-retrieval was per-
formed for 10 min at high temperature in citrate buffer. Then, slides were
blocked and incubated overnight with anti-TGIF, anti-b-catenin or IgG-
matched isotype control antibody (negative control) at 4C. Finally, slides
were incubated with the secondary antibody coupled to peroxidase for
30 min, incubated with peroxidase substrate, and mounted. The expression
of TGIF or b-catenin was visualized using a bright-field microscope.
The paraffin-embedded human samples (173) were purchased from US Bio-
max.Theuseof thesehumansampleswas exempted fromapproval by the insti-
tutional review board of INSERM or University of Mississippi Medical Center.
Real-Time PCR
cDNA synthesized with RNeasy-isolated RNA and SuperScript 3 (QIAGEN and
Invitrogen, respectively) was mixed with iQ SYBR green supermix (BioRad)
and sense and antisense oligonucleotides (500 nM). After cDNA amplification
(40 cycles), samples were normalized to GAPDH or cyclophilin A, and data
were expressed as mean ± SD of three to eight independent samples. The
primer sequences are available upon request.
Chromatin Immunoprecipitation
To analyze binding of b-catenin or TCF4 to the TGIF1 promoter, cells were
cultured under standard conditions, fixed, and sonicated using a standard pro-
tocol. Sonicated chromatin was then immunoprecipitated using antibodies
against b-catenin or TCF4 or isotype-matched control IgG. PCR was run on
the chromatin, and the products were analyzed in a 2% agarose gel. To
examine the effect of Wnt3a stimulation on b-catenin or TCF4 binding to the
TGIF1 promoter, cells were treated with control or Wnt3a CM for 24 hr before
being processed for chromatin sonication and immunoprecipitation with anti-
bodies against b-catenin or TCF4 or isotype-matched control IgG. Relative
DNA binding was determined by qRT-PCR.
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